Wahl Bryan
Insider CIK 1841401 · TARS General Counsel
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| TARS Tarsus Pharmaceuticals, In | S Sale | 2026-03-19 | 2026-03-19 | 4,231 | $67.00 | $283.5K | 63,959 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2026-03-18 | 2026-03-19 | 4,125 | $68.71 | $283.4K | 68,190 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2026-03-17 | 2026-03-19 | 4,084 | $69.42 | $283.5K | 72,315 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | M Exercise deriv | 2026-03-15 | 2026-03-17 | 7,176 | — | $0 | 14,351 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | M Exercise deriv | 2026-03-15 | 2026-03-17 | 5,022 | — | $0 | 15,067 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | M Exercise deriv | 2026-03-15 | 2026-03-17 | 4,790 | — | $0 | 0 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | M Exercise deriv | 2026-03-15 | 2026-03-17 | 7,248 | — | $0 | 7,249 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | M Exercise | 2026-03-15 | 2026-03-17 | 24,236 | — | $0 | 76,399 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | A Award deriv | 2026-03-05 | 2026-03-09 | 27,310 | — | $0 | 27,310 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | A Award deriv | 2026-03-05 | 2026-03-09 | 17,161 | — | $0 | 17,161 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2025-03-20 | 2025-03-20 | 3,084 | $50.11 | $154.5K | 51,712 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2025-03-19 | 2025-03-20 | 3,261 | $47.40 | $154.6K | 54,796 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2025-03-18 | 2025-03-20 | 3,341 | $46.29 | $154.7K | 58,057 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | M Exercise deriv | 2025-03-15 | 2025-03-18 | 4,790 | — | $0 | 4,790 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | M Exercise deriv | 2025-03-15 | 2025-03-18 | 7,248 | — | $0 | 14,497 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | M Exercise deriv | 2025-03-15 | 2025-03-18 | 7,175 | — | $0 | 21,527 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | M Exercise | 2025-03-15 | 2025-03-18 | 19,213 | — | $0 | 61,398 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | A Award deriv | 2025-03-05 | 2025-03-07 | 20,089 | — | $0 | 20,089 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | A Award deriv | 2025-03-05 | 2025-03-07 | 30,628 | — | $0 | 30,628 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2024-03-18 | 2024-03-19 | 4,436 | $30.60 | $135.7K | 40,951 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | M Exercise deriv | 2024-03-15 | 2024-03-19 | 4,790 | — | $0 | 9,580 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | M Exercise deriv | 2024-03-15 | 2024-03-19 | 7,248 | — | $0 | 21,745 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | M Exercise | 2024-03-15 | 2024-03-19 | 12,038 | — | $0 | 45,387 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | A Award deriv | 2024-03-07 | 2024-03-11 | 28,702 | — | $0 | 28,702 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | A Award deriv | 2024-03-07 | 2024-03-11 | 42,500 | — | $0 | 42,500 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2023-11-30 | 2023-12-01 | 8,356 | $16.31 | $136.3K | 31,966 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | M Exercise deriv | 2023-11-29 | 2023-12-01 | 23,920 | — | $0 | 0 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | M Exercise | 2023-11-29 | 2023-12-01 | 23,920 | — | $0 | 40,322 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2023-03-23 | 2023-03-23 | 371 | $12.15 | $4.5K | 16,402 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2023-03-22 | 2023-03-23 | 357 | $12.64 | $4.5K | 16,773 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2023-03-21 | 2023-03-23 | 350 | $12.89 | $4.5K | 17,130 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2023-03-20 | 2023-03-21 | 357 | $12.61 | $4.5K | 17,480 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2023-03-17 | 2023-03-21 | 339 | $13.28 | $4.5K | 17,837 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2023-03-16 | 2023-03-17 | 337 | $13.43 | $4.5K | 18,176 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | M Exercise deriv | 2023-03-15 | 2023-03-17 | 4,790 | — | $0 | 14,370 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | M Exercise | 2023-03-15 | 2023-03-17 | 4,790 | — | $0 | 18,513 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | A Award deriv | 2023-03-08 | 2023-03-10 | 28,993 | — | $0 | 28,993 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | A Award deriv | 2023-03-08 | 2023-03-10 | 42,802 | — | $0 | 42,802 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2022-12-02 | 2022-12-06 | 1,154 | $16.90 | $19.5K | 13,723 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2022-12-01 | 2022-12-01 | 1,164 | $16.75 | $19.5K | 14,877 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2022-11-30 | 2022-12-01 | 1,183 | $16.50 | $19.5K | 16,041 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | M Exercise deriv | 2022-11-29 | 2022-12-01 | 10,251 | — | $0 | 23,920 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | M Exercise | 2022-11-29 | 2022-12-01 | 10,251 | — | $0 | 17,224 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | A Award deriv | 2022-03-09 | 2022-03-11 | 65,312 | — | $0 | 65,312 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | A Award deriv | 2022-03-09 | 2022-03-11 | 19,160 | — | $0 | 19,160 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | A Award deriv | 2022-03-09 | 2022-03-11 | 34,171 | — | $0 | 34,171 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | A Award deriv | 2021-02-02 | 2021-02-02 | 89,368 | — | $0 | 89,368 | SEC↗ |